Helicobacter pylori eradication therapy, the reasonable first line therapy for gastric mucosa-associated lymphoid tissue lymphoma irrespective of infection status and disease stages

Dae Young Cheung

doi:10.5009/gnl16359

Helicobacter pylori eradication therapy, the reasonable first line therapy for gastric mucosa-associated lymphoid tissue lymphoma irrespective of infection status and disease stages

Dae Young Cheung

Department of Internal Medicine

Research output: Contribution to journal › Editorial

3 Scopus citations

Original language	English
Pages (from-to)	659-660
Number of pages	2
Journal	Gut and Liver
Volume	10
Issue number	5
DOIs	https://doi.org/10.5009/gnl16359
State	Published - Sep 2016

Access to Document

10.5009/gnl16359

Cite this

@article{eb7f977789b342649f4aab900388cc95,

title = "Helicobacter pylori eradication therapy, the reasonable first line therapy for gastric mucosa-associated lymphoid tissue lymphoma irrespective of infection status and disease stages",

author = "Cheung, \{Dae Young\}",

year = "2016",

month = sep,

doi = "10.5009/gnl16359",

language = "English",

volume = "10",

pages = "659--660",

journal = "Gut and Liver",

issn = "1976-2283",

publisher = "Editorial Office of Gut and Liver",

number = "5",

}

TY - JOUR

T1 - Helicobacter pylori eradication therapy, the reasonable first line therapy for gastric mucosa-associated lymphoid tissue lymphoma irrespective of infection status and disease stages

AU - Cheung, Dae Young

PY - 2016/9

Y1 - 2016/9

UR - https://www.scopus.com/pages/publications/84990045990

U2 - 10.5009/gnl16359

DO - 10.5009/gnl16359

M3 - Editorial

C2 - 27563015

AN - SCOPUS:84990045990

SN - 1976-2283

VL - 10

SP - 659

EP - 660

JO - Gut and Liver

JF - Gut and Liver

IS - 5

ER -

Helicobacter pylori eradication therapy, the reasonable first line therapy for gastric mucosa-associated lymphoid tissue lymphoma irrespective of infection status and disease stages

Access to Document

Other files and links

Cite this